Tutkimukset

Suomen munuaistautirekisterin tietoja käytetään tieteellisessä tutkimuksessa. Liitteenä tieteelliset julkaisut kymmenen vuoden ajalta, joissa rekisterin tiedot ovat toimineet tutkimusaineistona.

Jos haluat tietää enemmän Suomen munuaistautirekisterin aineiston käytöstä tieteellisessä tutkimuksessa, ota yhteys rekisterin vastaavaan lääkäriin Patrik Finneen patrik.finne@helsinki.fi


1. Helanterä I, Koljonen V, Finne P, Tukiainen E, Gissler M: The risk for end-stage renal disease is increased after burn. Burns, 2015.

2. Pippias M, Jager KJ, Kramer A, Leivestad T, Sanchez MB, Caskey FJ, Collart F, Couchoud C, Dekker FW, Finne P, Fouque D, Heaf JG, Hemmelder MH, Kramar R, De Meester J, Noordzij M, Palsson R, Pascual J, Zurriaga O, Wanner C, Stel VS: The changing trends and outcomes in renal replacement therapy: data from the ERAEDTA Registry. Nephrol Dial Transplant, 2015.

3. van de Luijtgaarden MW, Jager KJ, Segelmark M, Pascual J, Collart F, Hemke AC, Remon C, Metcalfe W, Miguel A, Kramar R, Aasarod K, Abu Hanna A, Krediet RT, Schön S, Ravani P, Caskey FJ, Couchoud C, Palsson R, Wanner C, Finne P, Noordzij M: Trends in dialysis modality choice and related patient survival in the ERAEDTA Registry over a 20-year period. Nephrol Dial Transplant, 2015.

4. Lofaro D, Jager KJ, Abu-Hanna A, Groothoff JW, Arikoski P, Hoecker B, Roussey-Kesler G, Spasojevic B, Verrina E, Schaefer F, van Stralen KJ, Registry EE-E: Identification of subgroups by risk of graft failure after paediatric renal transplantation: application of survival tree models on the ESPN/ERA-EDTA Registry. Nephrol Dial Transplant, 2015.

5. Pippias M, Stel VS, Areste-Fosalba N, Couchoud C, Fernandez- Fresnedo G, Finne P, Heaf JG, Hoitsma A, De Meester J, Palsson R, Ravani P, Segelmark M, Traynor JP, Reisaeter AV, Caskey FJ, Jager KJ: Long-term Kidney Transplant Outcomes in Primary Glomerulonephritis: Analysis From the ERA-EDTA Registry. Transplantation, 2015.

6. Koopman JJ, Rozing MP, Kramer A, Abad JM, Finne P, Heaf JG, Hoitsma AJ, De Meester JM, Palsson R, Postorino M, Ravani P, Wanner C, Jager KJ, van Bodegom D, Westendorp RG: Calculating the Rate of Senescence From Mortality Data: An Analysis of Data From the ERA-EDTA Registry. J Gerontol A Biol Sci Med Sci, 2015.

7. Vogelzang JL, van Stralen KJ, Noordzij M, Diez JA, Carrero JJ, Couchoud C, Dekker FW, Finne P, Fouque D, Heaf JG, Hoitsma

A, Leivestad T, de Meester J, Metcalfe W, Palsson R, Postorino M, Ravani P, Vanholder R, Wallner M, Wanner C, Groothoff JW, Jager KJ: Mortality from infections and malignancies in patients treated with renal replacement therapy: data from the ERA-EDTA registry. Nephrol Dial Transplant, 30: 1028-1037, 2015.

8. Pippias M, Stel VS, Abad Diez JM, Afentakis N, Herrero-Calvo JA, Arias M, Tomilina N, Bouzas Caamano E, Buturovic-Ponikvar J, Cala S, Caskey FJ, Castro de la Nuez P, Cernevskis H, Collart F, Alonso de la Torre R, Garcia Bazaga Mde L, De Meester J, Diaz JM, Djukanovic L, Ferrer Alamar M, Finne P, Garneata L, Golan E, Gonzalez Fernandez R, Gutierrez Avila G, Heaf J, Hoitsma A, Kantaria N, Kolesnyk M, Kramar R, Kramer A, Lassalle M, Leivestad T, Lopot F, Macario F, Magaz A, Martin-Escobar E, Metcalfe W, Noordzij M, Palsson R, Pechter U, Prutz KG, Ratkovic M, Resic H, Rutkowski B, Santiuste de Pablos C, Spustova V, Suleymanlar G, Van Stralen K, Thereska N, Wanner C, Jager KJ: Renal replacement therapy in Europe: a summary of the 2012 ERA-EDTA Registry Annual Report. Clin Kidney J, 8: 248-261, 2015.

9. Hruskova Z, Stel VS, Jayne D, Aasarod K, De Meester J, Ekstrand A, Eller K, Heaf JG, Hoitsma A, Martos Jimenez C, Ravani P, Wanner C, Tesar V, Jager KJ: Characteristics and Outcomes of Granulomatosis With Polyangiitis (Wegener) and Microscopic Polyangiitis Requiring Renal Replacement Therapy: Results From the European Renal Association-European Dialysis and Transplant Association Registry. Am J Kidney Dis, 66: 613-620, 2015.

10. Spithoven EM, Kramer A, Meijer E, Orskov B, Wanner C, Caskey F, Collart F, Finne P, Fogarty DG, Groothoff JW, Hoitsma A, Nogier MB, Postorino M, Ravani P, Zurriaga O, Jager KJ, Gansevoort RT, Registry E-E, Euro CC, Wgikd, Euro CC, Wgikd: Analysis of data from the ERA-EDTA Registry indicates that conventional treatments for chronic kidney disease do not reduce the need for renal replacement therapy in autosomal dominant polycystic kidney disease. Kidney Int, 86: 1244-1252, 2014.

11. Spithoven EM, Kramer A, Meijer E, Orskov B, Wanner C, Abad JM, Areste N, de la Torre RA, Caskey F, Couchoud C, Finne P, Heaf J, Hoitsma A, de Meester J, Pascual J, Postorino M, Ravani P, Zurriaga O, Jager KJ, Gansevoort RT, Registry E-E, Euro CC, Wgikd: Renal replacement therapy for autosomal dominant polycystic kidney disease (ADPKD) in Europe: prevalence and survival—an analysis of data from the ERA-EDTA Registry. Nephrol Dial Transplant, 29 Suppl 4: iv15-25, 2014.

12. Helve J, Sund R, Haapio M, Groop PH, Grönhagen-Riska C, Finne P: Medication among patients with type 1 diabetes and predialytic renal disease. Diabetes Res Clin Pract, 103: 510-515, 2014.

13. Helve J, Haapio M, Groop PH, Grönhagen-Riska C, Finne P: Biochemical variables and survival of patients with type 1 diabetes on renal replacement therapy. Blood Purif, 38: 18-23, 2014.

14. Helanterä I, Salmela K, Kyllönen L, Koskinen P, Grönhagen-Riska C, Finne P: Pretransplant dialysis duration and risk of death after kidney transplantation in the current era. Transplantation, 98: 458-464, 2014.

15. Harambat J, van Stralen KJ, Verrina E, Groothoff JW, Schaefer F, Jager KJ, Registry EE-E: Likelihood of children with end-stage kidney disease in Europe to live with a functioning kidney transplant is mainly explained by nonmedical factors. Pediatr Nephrol, 29: 453-459, 2014.

16. Harambat J, Bonthuis M, van Stralen KJ, Ariceta G, Battelino N, Bjerre A, Jahnukainen T, Leroy V, Reusz G, Sandes AR, Sinha MD, Groothoff JW, Combe C, Jager KJ, Verrina E, Schaefer F, Registry EE-E: Adult height in patients with advanced CKD requiring renal replacement therapy during childhood. Clin J Am Soc Nephrol, 9: 92-99, 2014.

17. Chesnaye N, Bonthuis M, Schaefer F, Groothoff JW, Verrina E, Heaf JG, Jankauskiene A, Lukosiene V, Molchanova EA, Mota C, Peco-Antic A, Ratsch IM, Bjerre A, Roussinov DL, Sukalo A, Topaloglu R, Van Hoeck K, Zagozdzon I, Jager KJ, Van Stralen KJ, registry EE-E: Demographics of paediatric renal replacement therapy in Europe: a report of the ESPN/ERA-EDTA registry. Pediatr Nephrol, 29: 2403-2410, 2014.

18. Van Stralen KJ, Verrina E, Belingheri M, Dudley J, Dusek J, Grenda R, Macher MA, Puretic Z, Rubic J, Rudaitis S, Rudin C, Schaefer F, Jager KJ, Registry EE-E: Impact of graft loss among kidney diseases with a high risk of post-transplant recurrence in the paediatric population. Nephrol Dial Transplant, 28: 1031-1038, 2013.

19. Haapio M, Helve J, Kyllönen L, Grönhagen-Riska C, Finne P: Modality of chronic renal replacement therapy and survival—a complete cohort from Finland, 2000-2009. Nephrol Dial Transplant, 28: 3072-3081, 2013.

20. van Stralen KJ, Krischock L, Schaefer F, Verrina E, Groothoff JW, Evans J, Heaf J, Ivanov D, Kostic M, Maringhini S, Podracka L, Printza N, Pundziene B, Reusz GS, Vondrak K, Jager KJ, Tizard EJ, Registry EE-E: Prevalence and predictors of the sub-target Hb level in children on dialysis. Nephrol Dial Transplant, 27: 3950- 3957, 2012.

21. van de Luijtgaarden MW, Noordzij M, Tomson C, Couchoud C, Cancarini G, Ansell D, Bos WJ, Dekker FW, Gorriz JL, Iatrou C, Garneata L, Wanner C, Cala S, Stojceva-Taneva O, Finne P, Stel VS, van Biesen W, Jager KJ: Factors influencing the decision to start renal replacement therapy: results of a survey among European nephrologists. Am J Kidney Dis, 60: 940-948, 2012.

22. Temme J, Kramer A, Jager KJ, Lange K, Peters F, Muller GA, Kramar R, Heaf JG, Finne P, Palsson R, Reisaeter AV, Hoitsma AJ, Metcalfe W, Postorino M, Zurriaga O, Santos JP, Ravani P, Jarraya F, Verrina E, Dekker FW, Gross O: Outcomes of male patients with Alport syndrome undergoing renal replacement therapy. Clin J Am Soc Nephrol, 7: 1969-1976, 2012.

23. Ocak G, van Stralen KJ, Rosendaal FR, Verduijn M, Ravani P, Palsson R, Leivestad T, Hoitsma AJ, Ferrer-Alamar M, Finne P, De Meester J, Wanner C, Dekker FW, Jager KJ: Mortality due to pulmonary embolism, myocardial infarction, and stroke among incident dialysis patients. J Thromb Haemost, 10: 2484-2493, 2012.

24. Kramer A, Jager KJ, Fogarty DG, Ravani P, Finne P, Perez-Panades J, Prutz KG, Arias M, Heaf JG, Wanner C, Stel VS: Association between pre-transplant dialysis modality and patient and graft survival after kidney transplantation. Nephrol Dial Transplant, 27: 4473-4480, 2012.

25. Kervinen M, Lehto S, Grönhagen-Riska C, Finne P: Effect of vascular comorbidities on survival of type 2 diabetes patients on renal replacement therapy. Am J Nephrol, 36: 509-515, 2012.

26. Helanterä I, Haapio M, Koskinen P, Grönhagen-Riska C, Finne P: Employment of patients receiving maintenance dialysis and after kidney transplant: a cross-sectional study from Finland. Am J Kidney Dis, 59: 700-706, 2012.

27. Harambat J, van Stralen KJ, Espinosa L, Groothoff JW, Hulton SA, Cerkauskiene R, Schaefer F, Verrina E, Jager KJ, Cochat P, European Society for Pediatric Nephrology/European Renal Association-European D, Transplant Association R: Characteristics and outcomes of children with primary oxalosis requiring renal replacement therapy. Clin J Am Soc Nephrol, 7: 458-465, 2012.

28. Haapio M, Helve J, Kurimo P, Forslund T, Grönhagen-Riska C, Finne P: Decline in glomerular filtration rate during pre-dialysis phase and survival on chronic renal replacement therapy. Nephrol Dial Transplant, 27: 1157-1163, 2012. 

29. Takala JH, Kautiainen H, Finne P, Leirisalo-Repo M: Wegener’s granulomatosis in Finland in 1981-2000: risk of dialysis-dependent renal disease. Scand J Rheumatol, 40: 283-288, 2011.

30. Koopman JJ, Rozing MP, Kramer A, de Jager DJ, Ansell D, De Meester JM, Prutz KG, Finne P, Heaf JG, Palsson R, Kramar R, Jager KJ, Dekker FW, Westendorp RG: Senescence rates in patients with end-stage renal disease: a critical appraisal of the Gompertz model. Aging Cell, 10: 233-238, 2011.

31. Helve J, Haapio M, Groop PH, Grönhagen-Riska C, Finne P: Comorbidities and survival of patients with type 1 diabetes on renal replacement therapy. Diabetologia, 54: 1663-1669, 2011.

32. Carrero JJ, de Jager DJ, Verduijn M, Ravani P, De Meester J, Heaf JG, Finne P, Hoitsma AJ, Pascual J, Jarraya F, Reisaeter AV, Collart F, Dekker FW, Jager KJ: Cardiovascular and noncardiovascular mortality among men and women starting dialysis. Clin J Am Soc Nephrol, 6: 1722-1730, 2011.

33. van Stralen KJ, Tizard EJ, Verrina E, Schaefer F, Jager KJ, European Society for Paediatric Nephrology/European Renal Association-European D, Transplant Association registry study g: Demographics of paediatric renal replacement therapy in Europe: 2007 annual report of the ESPN/ERA-EDTA registry. Pediatr Nephrol, 25: 1379-1382, 2010.

34. Tsakiris DJ, Stel VS, Finne P, Fraser E, Heaf J, de Meester J, Schmaldienst S, Dekker F, Verrina E, Jager KJ: Incidence and outcome of patients starting renal replacement therapy for end-stage renal disease due to multiple myeloma or light-chain deposit disease: an ERA-EDTA Registry study. Nephrol Dial Transplant, 25: 1200-1206, 2010.

35. Stel VS, Tomson C, Ansell D, Casino FG, Collart F, Finne P, Ioannidis GA, De Meester J, Salomone M, Traynor JP, Zurriaga O, Jager KJ: Level of renal function in patients starting dialysis: an ERA-EDTA Registry study. Nephrol Dial Transplant, 25: 3315-3325, 2010.

36. Kervinen M, Lehto S, Ikäheimo R, Karhapää P, Grönhagen-Riska C, Finne P: Improved survival of type 2 diabetic patients on renal replacement therapy in Finland. Nephrol Dial Transplant, 25: 892- 896, 2010.

37. Kastarinen M, Juutilainen A, Kastarinen H, Salomaa V, Karhapää P, Tuomilehto J, Grönhagen-Riska C, Jousilahti P, Finne P: Risk factors for end-stage renal disease in a community-based population: 26-year follow-up of 25,821 men and women in eastern Finland. J Intern Med, 267: 612-620, 2010.

38. Haapio M, Helve J, Groop PH, Grönhagen-Riska C, Finne P: Survival of patients with type 1 diabetes receiving renal replacement therapy in 1980-2007. Diabetes Care, 33: 1718-1723, 2010.

39. Stel VS, Dekker FW, Ansell D, Augustijn H, Casino FG, Collart F, Finne P, Ioannidis GA, Salomone M, Traynor JP, Zurriaga O, Verrina E, Jager KJ: Residual renal function at the start of dialysis and clinical outcomes. Nephrol Dial Transplant, 24: 3175-3182, 2009.

40. Kramer A, Stel V, Zoccali C, Heaf J, Ansell D, Grönhagen-Riska C, Leivestad T, Simpson K, Palsson R, Postorino M, Jager K, Registry E-E: An update on renal replacement therapy in Europe: ERA-EDTA Registry data from 1997 to 2006. Nephrol Dial Transplant, 24: 3557-3566, 2009.

41. de Jager DJ, Grootendorst DC, Jager KJ, van Dijk PC, Tomas LM, Ansell D, Collart F, Finne P, Heaf JG, De Meester J, Wetzels JF, Rosendaal FR, Dekker FW: Cardiovascular and noncardiovascular mortality among patients starting dialysis. JAMA, 302: 1782-1789, 2009.

42. Couchoud C, Kooman J, Finne P, Leivestad T, Stojceva-Taneva O, Ponikvar JB, Collart F, Kramar R, de Francisco A, Jager KJ: From registry data collection to international comparisons: examples of haemodialysis duration and frequency. Nephrol Dial Transplant, 24: 217-224, 2009.

43. Couchoud C, Jager KJ, Tomson C, Cabanne JF, Collart F, Finne P, de Francisco A, Frimat L, Garneata L, Leivestad T, Lemaitre V, Limido A, Ots M, Resic H, Stojceva-Taneva O, Kooman J: Assessment of urea removal in haemodialysis and the impact of the European Best Practice Guidelines. Nephrol Dial Transplant, 24: 1267-1274, 2009.

44. Immonen K, Finne P, Hakala M, Kautiainen H, Pettersson T, Grönhagen-Riska C: No improvement in survival of patients with amyloidosis associated with inflammatory rheumatic diseases -- data from the Finnish national registry for kidney diseases. J Rheumatol, 35: 1334-1338, 2008

45. van Dijk PC, Zwinderman AH, Dekker FW, Schön S, Stel VS, Finne P, Jager KJ: Effect of general population mortality on the north-south mortality gradient in patients on replacement therapy in Europe. Kidney Int, 71: 53-59, 2007. 

46. Yoshino M, Kuhlmann MK, Kotanko P, Greenwood RN, Pisoni RL, Port FK, Jager KJ, Homel P, Augustijn H, de Charro FT, Collart F, Erek E, Finne P, Garcia-Garcia G, Grönhagen-Riska C, Ioannidis GA, Ivis F, Leivestad T, Lokkegaard H, Lopot F, Jin DC, Kramar R, Nakao T, Nandakumar M, Ramirez S, van der Sande FM, Schon S, Simpson K, Walker RG, Zaluska W, Levin NW: International differences in dialysis mortality reflect background general population atherosclerotic cardiovascular mortality. J Am Soc Nephrol, 17: 3510-3519, 2006.

47. Stewart JH, McCredie MR, Williams SM, Fenton SS, Trpeski L, McDonald SP, Jager KJ, van Dijk PC, Finne P, Schön S, Leivestad T, Lokkegaard H, Billiouw JM, Kramar R, Magaz A, Vela E, Garcia- Blasco MJ, Ioannidis GA, Lim YN: The enigma of hypertensive ESRD: observations on incidence and trends in 18 European, Canadian, and Asian-Pacific populations, 1998 to 2002. Am J Kidney Dis, 48: 183-191, 2006.

48. Finne P, Reunanen A, Stenman S, Groop PH, Grönhagen-Riska C: Incidence of end-stage renal disease in patients with type 1 diabetes. JAMA, 294: 1782-1787, 2005.